Treatment of moderate‐to‐severe atopic dermatitis with baricitinib: Results from an interim analysis of the TREATgermany registry-Reference-Cited by-同舟云学术

Treatment of moderate‐to‐severe atopic dermatitis with baricitinib: Results from an interim analysis of the TREATgermany registry

Published:2024-03-28 Issue: Volume: Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Traidl Stephan¹²^ORCID,Heinrich Luise³,Siegels Doreen³^ORCID,Heratizadeh Annice¹^ORCID,Kind Barbara³,Haufe Eva³,Abraham Susanne⁴^ORCID,Schäfer Thomas⁵,Augustin Matthias⁶^ORCID,Harder Inken⁷,Pinter Andreas⁸^ORCID,Schäkel Knut⁹^ORCID,Wollenberg Andreas¹⁰¹¹¹²^ORCID,Ertner Konstantin¹³,Ramaker‐Brunke Jutta¹⁴,Bong Anne¹⁵,Quist Sven¹⁶,Gorriahn‐Maiterth Hannah¹⁷,Schenck Florian¹⁸,Sticherling Michael¹⁹,Effendy Isaak²⁰,Schwarz Beate²¹,Handrick Christiane²²,Asmussen Andrea²³,Weidinger Stephan⁷,Schmitt Jochen³,Werfel Thomas¹²,

Affiliation:

1. Department of Dermatology and Allergy Hannover Medical School Hannover Germany

2. Cluster of Excellence RESIST (EXC 2155) Hannover Medical School Hannover Germany

3. Center for Evidence‐Based Healthcare, University Hospital Carl Gustav Carus and Carl Gustav Carus Faculty of Medicine Technische Universitaet Dresden Dresden Germany

4. Department of Dermatology, University Allergy Center, Medical Faculty Carl Gustav Carus Technical University Dresden Dresden Germany

5. Practice Dr. Med. Thomas Schaefer/Dr. Med. Doreen Belz, Derma Koeln Köln Germany

6. Institute for Health Services Research in Dermatology Hamburg University Medical Center Hamburg Eppendorf Hamburg Germany

7. Center for Inflammatory Skin Diseases, Department of Dermatology and Allergy University Hospital Schleswig‐Holstein Kiel Germany

8. Department of Dermatology, Venereology and Allergology, Clinical Research University Hospital Frankfurt am Main Frankfurt am Main Germany

9. Department of Dermatology Ruprecht‐Karls University Heidelberg Heidelberg Germany

10. Department of Dermatology and Allergy Ludwig Maximilian University Munich Germany

11. Department of Dermatology and Allergy University Hospital Augsburg Augsburg Germany

12. Comprehensive Center for Inflammation Medicine University of Luebeck Luebeck Germany

13. Practice Dr. Med. Konstantin Ertner Nuernberg Germany

14. Practice ‘Die Hautärzte’ Braunschweig Braunschweig Germany

15. Practice Dr. Med. Anne Bong Emmerich Germany

16. Dermatology Clinic Helix Medical Excellence Center Mainz Mainz Germany

17. Practice Dermasana Karlsruhe Karlsruhe Germany

18. Dermatology Center Hannover Hannover Germany

19. Department of Dermatology University, German Center for Immunotherapy Erlangen Germany

20. Department of Dermatology Venereology and Allergology University Hospital – Medical School OWL – University of Bielefeld Bielefeld Germany

21. Practice Dr. Med. Beate Schwarz Langenau Germany

22. Practice Dr. Med. Christiane Handrick Berlin Germany

23. Practice Dr. Med. Andrea Asmussen, Dermatology at Lesum Bremen Germany

Funder

Pfizer

Lilly Deutschland

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.19979

Reference9 articles.

1. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children

2. Aktueller Stand zur Systemtherapie bei atopischer Dermatitis

3. Atopic dermatitis: an expanding therapeutic pipeline for a complex disease

4. Januskinaseinhibitoren zur Therapie der atopischen Dermatitis

5. Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis